Neoadjuvant Therapy Schemes combined with adjuvant Therapy for Patients   with muscle invasive Bladder Cancer before or after radical Cystectomy A   randomized, open, multicenter, global Phase-III Study to Determine the   Efficacy and Safety of Durvalumab in combination with Gemcitabine plus   Cisplatin (G plus C) for neoadjuvant Treatment, followed by Durvalumab   alone for adjuvant Treatment in Patients with muscle invasive Bladder   Cancer ( NIAGARA) - AUO AB 74/20

Document type:: Editorial Material
Author(s):: Rexer, Heidrun; Kuebler, Hubert; Retz, Margitta
Title:: Neoadjuvant Therapy Schemes combined with adjuvant Therapy for Patients with muscle invasive Bladder Cancer before or after radical Cystectomy A randomized, open, multicenter, global Phase-III Study to Determine the Efficacy and Safety of Durvalumab in combination with Gemcitabine plus Cisplatin (G plus C) for neoadjuvant Treatment, followed by Durvalumab alone for adjuvant Treatment in Patients with muscle invasive Bladder Cancer ( NIAGARA) - AUO AB 74/20
Journal title abbreviation:: Aktuelle Urol
Year:: 2021
Journal volume:: 52
Journal issue:: 03
Pages contribution:: 220-221
Fulltext / DOI:: doi:10.1055/a-1398-9963
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/34020502
Print-ISSN:: 0001-7868
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: